Citation Impact
Citing Papers
Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
1991
The density and spatial distribution of gabaergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia
2002
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
2012
Antidepressant effects of ketamine in depressed patients
2000 Standout
Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders
2000
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
1995
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
White matter hemisphere asymmetries in healthy subjects and in schizophrenia: a diffusion tensor MRI study
2004
Mapping brain asymmetry
2003 Standout
Modulation of anxiety through blockade of anandamide hydrolysis
2002 Standout
Neuroplasticity of Neocortical Circuits in Schizophrenia
2007
The neuropathology of schizophrenia
1999
Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects
1996
Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
1990
GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar Disorder
2001
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
2006 Standout
Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia
1998
Glutamate uptake
2001 Standout
Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain
2000
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Beyond the Dopamine Hypothesis
1989
Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABAA receptor α-1 subunit messenger RNA and human GABA transporter-1 (hGAT-1) messenger RNA expression
1999
Deficits of [3H]d-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia
1997
A systems model of altered consciousness: integrating natural and drug-induced psychoses
2001
The Atypical Neuroleptics Clozapine and Olanzapine Differ Regarding Their Antinociceptive Mechanisms and Potency
1999
The adolescent brain and age-related behavioral manifestations
2000 Standout
The high affinity uptake system for excitatory amino acids in the brain
1994
Network medicine: a network-based approach to human disease
2010 Standout
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)
1997
Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia
2004
Asymmetry of the Uncinate Fasciculus: A Post-mortem Study of Normal Subjects and Patients with Schizophrenia
2002
Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia
1994
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia
2002
Functional Imaging of Neural Responses to Expectancy and Experience of Monetary Gains and Losses
2001 StandoutNobel
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Driving fast-spiking cells induces gamma rhythm and controls sensory responses
2009 StandoutNature
Is Schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited
1994
Schizophrenia and the disconnection hypothesis
1999
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex
1997
Neuronal fast oscillations as a target site for psychoactive drugs
2000
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Bringing Order to the Glutamate Chaos in Schizophrenia
2003
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Substantia innominata: a notion which impedes clinical–anatomical correlations in neuropsychiatric disorders
1997
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
WAY 100135, an Antagonist of 5-HT1A Serotonin Receptors, Attenuates Psychotomimetic Effects of MK-801
2000
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia
2009
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
A Pivotal Role for Glutamate in the Pathogenesis of Schizophrenia, and Its Cognitive Dysfunction
1997
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
2008
Heterogeneity and Functional Properties of Subtypes of Sodium-Dependent Glutamate Transporters in the Mammalian Central Nervous System
1996
Neurochemical brain imaging investigations of schizophrenia
1999
Rethinking schizophrenia
2010 StandoutNature
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia
2008
(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
1989
The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex
2011
GABA Transporter-1 mRNA in the Prefrontal Cortex in Schizophrenia: Decreased Expression in a Subset of Neurons
2001
The Mechanism of Action of Novel Antipsychotic Drugs
1991
Gene Expression for Glutamic Acid Decarboxylase Is Reduced Without Loss of Neurons in Prefrontal Cortex of Schizophrenics
1995
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Cloned Glutamate Receptors
1994 Standout
Glutamate: a new target in schizophrenia?
1990
The molecular logic of endocannabinoid signalling
2003 Standout
Decreased Glutamic Acid Decarboxylase67 Messenger RNA Expression in a Subset of Prefrontal Cortical γ-Aminobutyric Acid Neurons in Subjects With Schizophrenia
2000
Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia
1998
Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization
1992
Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice
2000
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease
1999
Why do many psychiatric disorders emerge during adolescence?
2008 Standout
The role of 5-HT2A receptors in antipsychotic activity
1995
The GABAergic system in schizophrenia
2002
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
2001
Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans
2000
Meditation states and traits: EEG, ERP, and neuroimaging studies.
2006 Standout
Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia
2003
Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia
2006
Development, disease and degeneration in schizophrenia: a unitary pathophysiological model
1999
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
1996
Ligand-Gated Ion Channels: New Insights into Neurological Disorders and Ligand Recognition
2012
Antibody-Mediated Encephalitis
2018 Standout
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
The Glutamate Hypothesis of Schizophrenia
1997
Pharmacological interventions for somatoform disorders in adults
2014 Standout
A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia
1998
5-HT and mechanisms of defence
1991
When Fear Is Near: Threat Imminence Elicits Prefrontal-Periaqueductal Gray Shifts in Humans
2007 StandoutScienceNobel
Masked Presentations of Emotional Facial Expressions Modulate Amygdala Activity without Explicit Knowledge
1998 Standout
Short-Term Synaptic Plasticity
2002 Standout
Cortical inhibitory neurons and schizophrenia
2005 Standout
A glutamatergic deficiency model of schizophrenia
1999 StandoutNobel
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
1995
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
Neurotransmitter Transporters in the Central Nervous System
1999
Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons
1997
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Recent advances in the phencyclidine model of schizophrenia
1991 Standout
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics
1996
Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia
2008
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
Dopamine Receptors: From Structure to Function
1998 Standout
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
1998 Science
Physiology of Microglia
2011 Standout
The role of excitatory amino acids in neuropsychiatric illness
1990
Excitatory Amino Acid Receptors in Schizophrenia
1993
The neuropsychology of schizophrenia
1991
Works of M.D.C. Simpson being referenced
Loss of cortical GABA uptake sites in Alzheimer's disease
1988
Analysis of laminar distribution of kappa opiate receptor in human cortex: Comparison between schizophrenia and normal
1991
Alterations in phencyclidine and sigma binding sites in schizophrenic brains
1991
Age-related changes in binding to excitatory amino acid uptake site in temporal cortex of human brain
1992
A two-process theory of schizophrenia: Evidence from studies in post-mortem brain
1997
Identification and distribution of 5-HT3 recognition sites within the human brainstem
1990
Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia
1989
Sodium dependent d-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases
1987
Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia
1992
Reduced GABA uptake sites in the temporal lobe in schizophrenia
1989
Reduced d-[3H]aspartate binding in Down's syndrome brains
1989
Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia
1996
The neurochemistry of schizophrenia
1994
Social signalling and schizophrenia: The significance of neurochemical and morphological abnormalities of the basolateral circuit
1991
Distributed brain glutamate and GABA mechanisms in schizophrenia
1990
Familial and developmental abnormalities of frontal lobe function and neurochemistry in schizophrenia
1997
Neurochemical abnormalities of the cerebral cortex in schizophrenia
1992